Bioventus (BVS) FCF Margin Growth (1y) (2021 - 2026)
Bioventus (BVS) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2,811.00 |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | 2,263.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2,263.00 |
| Dec 31, 2025 | 1,168.00 |
| Sep 27, 2025 | 1,293.00 |
| Jun 28, 2025 | 791.00 |
| Mar 29, 2025 | -1,141.00 |
| Dec 31, 2024 | 434.00 |
| Sep 28, 2024 | 1,645.00 |
| Jun 29, 2024 | 32.00 |
| Mar 30, 2024 | -579.00 |
| Dec 31, 2023 | -77.00 |
| Sep 30, 2023 | -780.00 |
| Jul 1, 2023 | 1,117.00 |
| Apr 1, 2023 | 1,891.00 |
| Dec 31, 2022 | 523.00 |
| Oct 1, 2022 | -732.00 |
| Jul 2, 2022 | -1,670.00 |
| Apr 2, 2022 | 427.00 |
| Dec 31, 2021 | -2,464.00 |
| Oct 2, 2021 | -1,540.00 |
| Jul 3, 2021 | 132.00 |